FDA warns of fraudulent data coming from third party labs
The US Food and Drug Administration has warned that some third-party labs, many based out of India and China, are producing false or duplicated data.
22 February 2024
22 February 2024
The US Food and Drug Administration has warned that some third-party labs, many based out of India and China, are producing false or duplicated data.
The acquisition forms part of Aptar Digital Health's plan to expand its portfolio in the neurology sector.
Devices that claim to non-invasively measure blood sugar are illegally marketed, the US agency states.
The Symani Surgical System is designed to address the scale and complexities of microsurgery and supermicrosurgery.
The collaboration aims to increase cervical cancer screening rates in the country.
The Chinese company has received marketing approval for five devices in the United Arab Emirates (UAE).
Santersus will provide NucleoCapture and HemoNucleoCapture devices to Aethlon.
The funding will support clinical trials slated to commence in H1 2024 and develop the device’s wireless power source.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.